This brain implant can reverse paralysis.
His brain implant made headlines in 2016. Now, he’s fighting for everyone to afford one.
By Chuck Brooks
Realizing the potential of Smart Cities will require public-private cooperation and security by design.
The idea of smart cities is starting to take shape as the digital era develops. A city that has developed a public-private infrastructure to support waste management, energy, transportation, water resources, smart building technology, sustainability, security operations and citizen services is referred to as a “smart city”. Realizing the potential of Smart Cities will require public-private cooperation and security by design.
Continue reading “The Emergence Of Smart Cities In The Digital Era” »
Evolution has produced a range of diverse proteins, and now a generative model called Chroma can expand that set by allowing the user to design new proteins and protein complexes with desired properties and functions.
The first cellular map of a mammalian brain is here.
High-resolution atlas charts neural neighborhoods for more than 5,300 cell types.
A stroke happens when blood flow is lost to part of the brain. Your brain cells cannot get the oxygen and nutrients they need from blood, and they start to die in a few minutes. This can cause lasting brain damage, long-term disability, or even death.
A stroke can occur when an obstruction such as a blood clot travels from another part of the body and lodges inside an artery in the brain.
When an arterial wall becomes damaged, various types of emboli, or obstructions, can form. Emboli can be made up of various substances such as platelets, elements in the blood that help it clot, blood clots that form elsewhere and pass to the damaged area, cholesterol, or a combination of things.
Continue reading “Stroke — Health Video: MedlinePlus Medical Encyclopedia” »
Moore’s Law predicts that computers get faster every two years because of the evolution of semiconductor chips.
Researchers at Tohoku University and the University of California, Santa Barbara, have shown a proof-of-concept of energy-efficient computer compatible with current AI. It utilizes a stochastic behavior of nanoscale spintronics devices and is particularly suitable for probabilistic computation problems such as inference and sampling.
The team presented the results at the IEEE International Electron Devices Meeting (IEDM 2023) on December 12, 2023.
In December 2022, NASA’s MAVEN mission observed a rare solar event causing the solar wind to “disappear.” This led to significant changes in Mars’ atmosphere and magnetosphere, including their expansion. Scientists, astounded by the data, formed a working group to study this phenomenon. Credit: SciTechDaily.com.
NASA ’s MAVEN detected a unique solar event that drastically affected Mars ’ atmosphere, offering vital insights into the planet’s interaction with solar phenomena.
Our most advanced text-to-image diffusion technology, delivering high-quality, photorealistic outputs that are closely aligned and consistent with the user’s prompt.
Imagen 2 is our most advanced text-to-image diffusion technology, delivering high-quality, photorealistic outputs that are closely aligned and consistent with the user’s prompt. It can generate more lifelike images by using the natural distribution of its training data, instead of adopting a pre-programmed style.
Imagen 2’s powerful text-to-image technology is available for developers and Cloud customers via the Imagen API in Google Cloud Vertex AI.
Continue reading “Imagen 2: Google DeepMind announced Imagen 2” »
https://youtube.com/watch?v=D79hFytvCgk
Tesla has released a demo of their Gen 2 Tesla Bot with impressive advancements in design and capabilities, sparking discussion about its potential impact on manufacturing and the company’s success.
Questions to inspire discussion.
Headquartered in Oxford, UK, MitoRx is working on orally delivered mitochondrial protective therapeutics targeting mitochondrial dysfunction linked to the progression of conditions such as Duchenne muscular dystrophy and Huntington’s disease, along with other neurodegenerative diseases. The company says the new funding will be allocated towards its preclinical work in Huntington’s disease, activating its first neurodegenerative disease program, and exploring research collaborations and partnerships.
MitoRx anticipates delivering preclinical results in Duchenne muscular dystrophy, Huntington’s disease, and COPD next year.
“Interim results in our Duchenne program demonstrate that our muscle-penetrative lead asset preserves strength in oxidative muscle, and confirms mitochondrial modulation,” said Dr Christine Charman, Chief Development Officer at MitoRx. “These results will be presented at the Muscular Dystrophy Association Clinical and Scientific Conference in Orlando during March 2024.”
